Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of SOBDA Questionnaire in COPD
NCT00984659Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Oct 2009; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00984659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984659.